2025-01-22 - Analysis Report
## Eli Lilly and Co. (LLY) Stock Analysis Report

**1. Performance Comparison and Outperformance:**

Eli Lilly and Co. (LLY) is a global pharmaceutical company that researches, develops, manufactures, and markets pharmaceutical products.  The cumulative return of LLY is significantly higher than that of the S&P 500 (VOO).  The difference in cumulative returns as of the last date in the provided data is 410.1%, placing it at the 66th percentile of its historical range relative to the S&P 500. This indicates substantial outperformance.  The table below shows the Compound Annual Growth Rate (CAGR) significantly exceeding the market, as evidenced by the substantial Alpha values.  Note that the provided Alpha values of 0.0 are likely an error in the data.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 12.0% | 14.9% | **Error** | 0.0 | 668.0 |
| 2016-2018  | 42.0% | 14.9% | **Error** | 0.0 | 668.0 |
| 2017-2019  | 63.0% | 13.8% | **Error** | 0.0 | 668.0 |
| 2018-2020  | 86.0% | 20.5% | **Error** | 0.0 | 668.0 |
| 2019-2021  | 152.0% | 20.5% | **Error** | 0.0 | 668.0 |
| 2020-2022  | 205.0% | 20.5% | **Error** | 0.0 | 668.0 |
| 2021-2023  | 349.0% | 18.4% | **Error** | 0.0 | 668.0 |
| 2022-2024  | 367.0% | 23.9% | **Error** | 0.0 | 668.0 |
| 2023-2025  | 266.0% | 23.9% | **Error** | 0.0 | 668.0 |


**2. Recent Price Movement:**

* **Closing Price:** $742.35
* **5-Day Moving Average:** $743.46
* **20-Day Moving Average:** $772.04
* **60-Day Moving Average:** $793.94

The price is currently below all three moving averages, suggesting a potential short-term downtrend.  However, the recent price change shows a slight increase from the previous close ($2.29), which warrants further investigation into potential catalysts.

**3. Technical Indicators and Expected Return:**

* **RSI:** 39.2 – Suggests the stock is approaching oversold territory.
* **PPO:** -0.51 – Indicates bearish momentum.
* **Delta_Previous_Relative_Divergence:** -8.3% – Shows a recent decrease in relative strength.

The relatively small price increase of $2.29 from the previous close does not signify a significant price jump (not a "sudden surge"). The expected return of 142.9% over the long term (2+ years) relative to the S&P 500 is very high and should be interpreted cautiously.  This prediction should be considered a high estimate with inherent uncertainty.


**4. Recent Earnings Analysis:**

The provided earnings data shows significant variability in EPS and revenue. There are inconsistencies in the provided data (duplicate entries for 2024-10-30).  A more reliable and complete data set is needed for a thorough analysis.  However, it appears there is considerable quarter-to-quarter variation.


**5. Financial Information Analysis:**

Revenue remains relatively consistent, with some quarter-to-quarter fluctuations. Profit margins are consistently high (around 80%). Equity and ROE show volatility, which needs further investigation for determining the underlying causes.  The negative ROE in 2023-09-30 is concerning and needs further explanation.


**7. Overall Analysis:**

LLY has significantly outperformed the S&P 500 over the observed period.  However, recent technical indicators suggest a possible short-term downturn.  The high expected return is a significant positive, but should be viewed with skepticism given its magnitude and the inherent uncertainties in long-term predictions.  Inconsistencies in the earnings and financial data necessitate further investigation.  A thorough fundamental analysis, considering factors like competitive landscape, pipeline development, and regulatory risks, is crucial before making any investment decisions. The high volatility in ROE and the occasional negative ROE are significant concerns that need further analysis to understand the reasons and their implications.

**8. Disclaimer:** This report is for informational purposes only and does not constitute financial advice.  Investment decisions should be made based on your own research and risk tolerance.  Consult a qualified financial advisor before making any investment decisions.
